Non-alcoholic fatty liver disease and childhood obesity
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Obesity has emerged as a significant global health problem in the pediatric population. Pediatric liver disease is a serious complication of childhood obesity. Non-alcoholic steatohepatitis (NASH) is an entity in the spectrum of non-alcoholic fatty liver disease (NAFLD) ranges from fat in the liver — simple steatosis, NASH/ steatohepatitis — fat with in ammation and/or fibrosis to advanced fibrosis and cirrhosis when fat may no longer be present. NASH is associated with obesity, diabetes, insulin resistance (IR), and hypertriglyceridemia. Children get NAFLD, and the incidence of this pediatric liver disease is rising as childhood obesity becomes increasingly prevalent. Although much remains to be learned about pediatric NAFLD, it is already evident that children with NASH risk progressive liver damage, including cirrhosis. Liver biopsy is required for definitive diagnosis, and other causes of fatty liver in childhood must be excluded. Gradual weight loss through increased regular exercise and a low-fat, low-refined carbohydrate diet appears to be effective. Drug treatments are being developed. The important message is that childhood obesity poses important health problems, including but not limited to potentially severe chronic liver disease. Early diagnosis of children who are only overweight is a worthy goal so that strategies to limit obesity can be instituted as early as possible. Identification of genetic risks is important, but management will invariably require changes in environmental factors. In addition to individual treatment, a multifaceted, societal initiative is required for solving the childhood obesity epidemic.
- Kaur S, Kapil U, Singh P. Pattern of chronic diseases amongst adolescent obese children in developing countries. Curr Sci 2005; 88(7): 1052–1056.
- Moran JR, Ghishen FK, Halter SA, Greene HL. et al. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol 1983; 78(6): 374–377.
- Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346(16): 1221–1229. CrossRef
- Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK et al. (2004). Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28: 1257–1263. CrossRef
- Bergomi AL, Iughetti N, Corciulo P et al. Italian multicenter study on liver damage in pediatric obesity. Int J Obes Relat Metab Disord 1998; 22(suppl 4): S22.
- Guzzaloni G, Grugni G, Minocci A et al. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000; 24(6): 772–776. CrossRef
- Engelmann G, Lenhartz H, Grulich-Henn J. Obesity and metabolic syndrome in children and adolescents. N Engl J Med 2004; 351(11): 1146. CrossRef
- Rashid M, Roberts EA. Non alcoholic steatohepatitis in children. J Pediatr Gastro Nutr 2000; 30(1): 48–53. CrossRef
- Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26–31. CrossRef
- Sanyal AJ. AGA Technical Review on Nonalcoholic Fatty Liver Disease. Gastroenterol 2002; 123: 1705–1725. CrossRef
- Fishbein MH, Miner M, Mogren C, Chalekson J. The spectrum of fatty liver in obese children and the relationship of serum aminotransferases to severity of steatosis. J Pediatr Gastro Nutr 2003; 36(1): 54–61. CrossRef
- Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferases values in overweight and obese adolescents. J Pediatrics 2000; 136: 727–733. CrossRef
- Manton ND, Lipsett J, Moore DJ, Davidson GP, Bourne AJ, Couper RTL. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust 2000; 173: 476–479.
- Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Effect of weight reduction on serum transaminases activities in children with simple obesity. J Pediatr 1996; 128(4): 587–588
- Franzese A, Vajro P, Argenziano et al. Liver involvement in obese children: Ultrasonography and liver enzyme levels at diagnosis and during follow up in an Italian population. Dig Dis Sci 1997; 42(7): 1428–1432. CrossRef
- Vajro P, Fontanella A, Perna C, Orso G, Tedescom, Vincenzo AD. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994; 125: 239–241. CrossRef
- Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese children. J Pediatr Gastro Nutr 1997; 24: 317–321. CrossRef
- Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gatroenterol Nutrit 1984; 3: 408–414. CrossRef
- Tominaga K, Kurata JH, Chen YK et al. Prevalence of fatty liver in Japanese children and relationship to obesity. Dig Dis Sci 1995; 40(9): 2002–2009. CrossRef
- Yamazaki K, Ichikawa M, Kazuma M, Shimizu H, Murata M. The risk of obesity in children (in Japanese). Pediatr Jpn 1987; 28: 619–623.
- Murata M, Yamazaki K, Kanetugu K, Hoshina K. The hepatic injury of obesity in children (in Japanese). Jpn Med J 1976; 2724: 28–32.
- Baldridge AD, Atayde ARP, Cook FG, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: A multi-centric retrospective study. J Pediatrics 1995; 127(5): 700–704. CrossRef
- Saadeh S, Younossi ZM, Remer EM et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–750. CrossRef
- Hultcrantz R, Gabrielsson N. Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 1993; 233: 7–12. CrossRef
- Sanford NL, Walsh P, Matis C, Baddeley H, Powell LW. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology 1985; 89: 186–191.
- Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998; 15: 246–258.
- Schwimmer JB, Behling C, Newbury R et al. Histopathology of Pediatric Nonalcoholic Fatty Liver Disease. Hepatology 2005; 42: 641–649. CrossRef
- Xanthokos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T. Histologic spectrum of Nonalcoholic Fatty Liver Disease in Morbidly Obese Adolescents. Clin Gastrol Hepatol 2006; 4: 226–232. CrossRef
- Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance and other clinicopathological correlates of Pediatric Nonalcoholic fatty liver disease. J Pediatrics 2003; 143: 500–505. CrossRef
- Kerkar N. Non-alcoholic steatohepatitis in children. Pediatr Transplantation 2004; 8: 613–618. CrossRef
- Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study. J Pediatr 2000; 136: 734–738. CrossRef
- Yu AS, Keeffe EB. Nonalcoholic Fatty Liver Disease. Rev Gastroenterol Disord 2002; 2(1): 11–19.
- Non-alcoholic fatty liver disease and childhood obesity
The Indian Journal of Pediatrics
Volume 74, Issue 4 , pp 401-408
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Childhood obesity
- Non-alcoholic fatty liver disease
- Risk factors
- Industry Sectors